1 / 8

Chemotherapy Induced Peripheral Neuropathy Global Clinical

GlobalData's clinical trial report, “Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Chemotherapy Induced Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chemotherapy Induced Peripheral Neuropathy. Detailed report at: http://www.reportsandintelligence.com/chemotherapy-induced-peripheral-neuropathy-global-clinical-trials-review-h2-2014-market

SarahPalin111
Download Presentation

Chemotherapy Induced Peripheral Neuropathy Global Clinical

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014 Publisher: Global Data No of pages: 129 Publish Date: Oct2014

  2. Description GlobalData's clinical trial report, “Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Chemotherapy Induced Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chemotherapy Induced Peripheral Neuropathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chemotherapy Induced Peripheral Neuropathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Enquire about report at: http://www.reportsandintelligence.com/enquire-about-report/133252

  3. Scope • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type • Listings of discontinued trials (suspended, withdrawn and terminated) • Get all reports of Pharmaceutical category at: http://www.reportsandintelligence.com/pharmaceuticals-market-report

  4. Reasons to buy • Understand the dynamics of a particular indication in a condensed manner • A bridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more • Obtain discontinued trial listing for trials across the globe • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies • View detailed report at: http://www.reportsandintelligence.com/chemotherapy-induced-peripheral-neuropathy-global-clinical-trials-review-h2-2014-market

  5. Table Of Content Table of Contents 2List of Tables 4List of Figures 6Introduction 7Chemotherapy Induced Peripheral Neuropathy 7Report Guidance 7Clinical Trials by Region 8Clinical Trials and Average Enrollment by Country 9Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11Top Five Countries Contributing to Clinical Trials in Europe 12Top Countries Contributing to Clinical Trials in North America 13Top Five Countries Contributing to Clinical Trials in Central and South America 14Clinical Trials by G7 Countries: Proportion of Chemotherapy Induced Peripheral Neuropathy to Oncology Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17

  6. Table Of Content Clinical Trials by E7 Countries: Proportion of Chemotherapy Induced Peripheral Neuropathy to Oncology Clinical Trials 18Clinical Trials by Phase in E7 Countries 19Clinical Trials in E7 Countries by Trial Status 20Clinical Trials by Phase 21In Progress Trials by Phase 22Clinical Trials by Trial Status 23Clinical Trials by End Point Status 24Unaccomplished Trials of Chemotherapy Induced Peripheral Neuropathy 25Subjects Recruited Over a Period of Time 27Clinical Trials by Sponsor Type 28Prominent Sponsors 29Top Companies Participating in Chemotherapy Induced Peripheral Neuropathy Therapeutics Clinical Trials 30Prominent Drugs 32Clinical Trial Profiles 33Clinical Trial Overview of Top Companies 33

  7. Table Of Content Pfizer Inc. 33Clinical Trial Overview of Pfizer Inc. 33Spectrum Pharmaceuticals, Inc. 34Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 34Sigma-Tau S.p.A. 35Clinical Trial Overview of Sigma-Tau S.p.A. 35Sanofi 36Clinical Trial Overview of Sanofi 36Immune Pharmaceuticals, Inc. 37Clinical Trial Overview of Immune Pharmaceuticals, Inc. 37DARA BioSciences, Inc. 38Clinical Trial Overview of DARA BioSciences, Inc. 38 Get full TOC at: http://www.reportsandintelligence.com/chemotherapy-induced-peripheral-neuropathy-global-clinical-trials-review-h2-2014-market/table-of-contents

  8. FOR MORE DETAILS Visit us at : http://www.reportsandintelligence.com/chemotherapy-induced-peripheral-neuropathy-global-clinical-trials-review-h2-2014-market Stay With Us: • TELEPHONE: Direct: +1 (617) 674-4143 • Toll Free: +1 (855) 711-1555E-MAIL: sales@reportsandintelligence.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States

More Related